Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.

Research output: Contribution to journal › Letter › peer-review

Subject classification (UKÄ)

@article{9cbb2efe29f64f57b50da0aeffa172ea,

title = "Most 70- to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment.",

author = "Gunnar Juliusson",

year = "2011",

doi = "10.1182/blood-2010-11-321737",

language = "English",

volume = "117",

pages = "3473--3474",

journal = "Blood",

issn = "1528-0020",

publisher = "American Society of Hematology",

number = "12",

}